Evidence reviewSupplementsEvidence Tier I

Is Creatine Safe and Does It Offer Benefits Beyond Muscle Function?

Creatine is a well-researched supplement primarily known for enhancing athletic performance and muscle mass. This article examines the safety profile of creatine and critically evaluates the emerging evidence for its potential effects on brain health and other non-muscular systems.

Dr. Eleanor Vance, MD, PhD
May 1, 2026
4 min read

The short answer

Creatine monohydrate is generally considered safe for healthy individuals when consumed within recommended dosages, with decades of research supporting its efficacy for enhancing muscle strength and power. Evidence for benefits beyond muscle, particularly for brain function, is emerging but less robust, warranting further investigation.

What the evidence actually shows

The safety of creatine monohydrate has been extensively investigated, with numerous Tier I studies and meta-analyses consistently demonstrating its safety profile in healthy populations across various age groups. Long-term studies, some extending up to five years, have found no adverse effects on kidney or liver function, even at doses up to 30g/day, provided individuals are healthy and properly hydrated (Kreider et al., Journal of the International Society of Sports Nutrition, 2017). Concerns regarding kidney damage, often perpetuated in anecdotal reports, are not supported by the scientific literature. For muscular benefits, the evidence is unequivocal: creatine supplementation significantly increases muscle phosphocreatine stores, leading to improved high-intensity exercise performance, increased strength, and greater lean body mass (Dolan et al., Nutrients, 2019). Beyond muscle, a growing body of Tier II evidence suggests potential cognitive benefits, particularly in situations of sleep deprivation or mental fatigue, and in certain neurological conditions. Studies have shown improvements in working memory and intelligence scores in vegetarians and older adults, who typically have lower baseline creatine levels (Roschel et al., Journal of the International Society of Sports Nutrition, 2021). However, these cognitive effects are not universally observed across all populations or cognitive domains.

Creatine monohydrate is the most extensively studied and clinically effective form of creatine for use in nutritional supplements in terms of muscle uptake and ability to increase high-intensity exercise capacity.

Kreider et al., Journal of the International Society of Sports Nutrition, 2017

Where Harvard Health gets it right

Harvard Health generally acknowledges creatine's efficacy for improving athletic performance and muscle strength, aligning with the vast body of Tier I evidence. They correctly identify creatine as one of the most researched supplements and often highlight its utility for athletes and those seeking to increase muscle mass. Their guidance typically refrains from sensationalising the potential risks, acknowledging that for most healthy individuals, creatine monohydrate is safe when used appropriately. They also often correctly point out that individual responses to creatine can vary, which is a nuanced but important detail supported by research into genetic variations in creatine transporter efficiency.

Where the evidence is more nuanced

While Harvard Health often presents a balanced view, the emphasis on creatine's 'beyond muscle' benefits can sometimes be oversimplified or presented with less qualification than the evidence warrants. The cognitive benefits, for instance, are not as universally established or as potent as its muscular effects. Many studies showing cognitive improvements are Tier II (smaller RCTs, specific populations like vegetarians or the elderly) and the magnitude of effect is generally modest. Claims of widespread neuroprotective effects or significant cognitive enhancement in healthy, well-fed individuals without specific deficits are still largely speculative and not supported by robust Tier I evidence. Similarly, while creatine is being explored for various clinical applications (e.g., depression, Parkinson's disease), these remain largely experimental with mixed results, and the evidence is far from conclusive for general recommendation (Gualano et al., Amino Acids, 2012).

Practical implications

For individuals looking to enhance athletic performance, increase muscle mass, or improve recovery from high-intensity exercise, creatine monohydrate is a well-supported and safe supplement. A typical dosing strategy involves a 'loading phase' of 20g/day (divided into four 5g doses) for 5-7 days, followed by a 'maintenance phase' of 3-5g/day. For those interested in potential cognitive benefits, particularly vegetarians or older adults, a maintenance dose of 3-5g/day may be considered, though expectations should be modest. It is crucial to ensure adequate hydration when supplementing with creatine. Individuals with pre-existing kidney conditions or those taking nephrotoxic medications should consult a healthcare professional before use. Always opt for reputable brands to ensure product purity and potency.

Vitaei verdict

Supported by the evidence for muscle performance and safety. Partially supported for cognitive benefits, with efficacy more pronounced in specific populations or conditions.

Where reasonable people still disagree

  • The optimal dosing strategy for long-term cognitive enhancement in healthy individuals.
  • The clinical significance of creatine supplementation in specific neurological conditions, given mixed trial results.
  • Whether different forms of creatine (e.g., creatine ethyl ester, buffered creatine) offer any superior benefits or absorption compared to creatine monohydrate.

Related Molecules